Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy IGM Biosciences stock | $50.96

Learn how to easily invest in IGM Biosciences stock.

IGM Biosciences Inc is a biotechnology business based in the US. IGM Biosciences shares (IGMS) are listed on the NASDAQ and all prices are listed in US Dollars. IGM Biosciences employs 144 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in IGM Biosciences

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – IGMS – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

IGM Biosciences stock price (NASDAQ: IGMS)

Use our graph to track the performance of IGMS stocks over time.

IGM Biosciences shares at a glance

Information last updated 2021-10-23.
Latest market close$50.96
52-week range$42.00 - $127.11
50-day moving average $65.94
200-day moving average $73.45
Wall St. target price$103.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-3.58

Buy IGM Biosciences shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy IGM Biosciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

IGM Biosciences price performance over time

Historical closes compared with the close of $50.96 from 2021-10-25

1 week (2021-10-19) -5.79%
1 month (2021-09-24) -29.56%
3 months (2021-07-26) -38.05%
6 months (2021-04-26) -24.26%
1 year (2020-10-26) -13.82%
2 years (2019-10-25) 121.28%
3 years (2018-10-22) N/A
5 years (2016-10-22) N/A

IGM Biosciences financials

Gross profit TTM $-39,161,000
Return on assets TTM -24.96%
Return on equity TTM -43.54%
Profit margin 0%
Book value $10.06
Market capitalisation $1.7 billion

TTM: trailing 12 months

Shorting IGM Biosciences shares

There are currently 3.2 million IGM Biosciences shares held short by investors – that's known as IGM Biosciences's "short interest". This figure is 1% down from 3.2 million last month.

There are a few different ways that this level of interest in shorting IGM Biosciences shares can be evaluated.

IGM Biosciences's "short interest ratio" (SIR)

IGM Biosciences's "short interest ratio" (SIR) is the quantity of IGM Biosciences shares currently shorted divided by the average quantity of IGM Biosciences shares traded daily (recently around 124525.70866142). IGM Biosciences's SIR currently stands at 25.4. In other words for every 100,000 IGM Biosciences shares traded daily on the market, roughly 25400 shares are currently held short.

However IGM Biosciences's short interest can also be evaluated against the total number of IGM Biosciences shares, or, against the total number of tradable IGM Biosciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case IGM Biosciences's short interest could be expressed as 0.1% of the outstanding shares (for every 100,000 IGM Biosciences shares in existence, roughly 100 shares are currently held short) or 0.394% of the tradable shares (for every 100,000 tradable IGM Biosciences shares, roughly 394 shares are currently held short).

A SIR above 20% would generally be considered very high, pointing to a pessimistic outlook for the share price, with a discouraging number of investors currently willing to bet against IGM Biosciences.

Find out more about how you can short IGM Biosciences stock.

IGM Biosciences share dividends

We're not expecting IGM Biosciences to pay a dividend over the next 12 months.

IGM Biosciences share price volatility

Over the last 12 months, IGM Biosciences's shares have ranged in value from as little as $42 up to $127.11. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while IGM Biosciences's is -1.0478. This would suggest that IGM Biosciences's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, IGM Biosciences has bucked the trend.

IGM Biosciences overview

IGM Biosciences, Inc. , a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of multiple diseases. Its lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 1 clinical trials to treat patients with relapsed/refractory B cell Non-Hodgkin's lymphoma (NHL). The company is also developing IGM-8444, an IgM antibody, which is in Phase 1 clinical trials for the treatment of patients with solid cancers and NHL; and IGM-7354, is a bispecific IgM antibody delivering interleukin-15 cytokines to PD-L1 expressing cells for use in the treatment of patients with solid and hematologic malignancies. It has a strategic research and license agreement with AbCellera to discover and develop IgM antibodies; and license agreement with AvantGen Inc. for various antibodies against the SARS-CoV-2 virus. The company was formerly known as Palingen, Inc.

Frequently asked questions

What percentage of IGM Biosciences is owned by insiders or institutions?
Currently 43.153% of IGM Biosciences shares are held by insiders and 66.259% by institutions.
How many people work for IGM Biosciences?
Latest data suggests 144 work at IGM Biosciences.
When does the fiscal year end for IGM Biosciences?
IGM Biosciences's fiscal year ends in December.
Where is IGM Biosciences based?
IGM Biosciences's address is: 325 East Middlefield Road, Mountain View, CA, United States, 94043
What is IGM Biosciences's ISIN number?
IGM Biosciences's international securities identification number is: US4495851085
What is IGM Biosciences's CUSIP number?
IGM Biosciences's Committee on Uniform Securities Identification Procedures number is: 449585108

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site